Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2719 results

Sort By:

A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market

Study ID: NCT06760208
Start Date: 2025-11-28
End Date: 2028-10-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

660

Intervention / Treatment

Pneumococcal 20-valent conjugate vaccine

Sponsor

Pfizer

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of DPA for Treatment of Upper Anterior Crowding

Study ID: NCT06625658
Start Date: 2026-01-10
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

9

Intervention / Treatment

Direct printed clear aligners

Sponsor

Samia Omar

Source: clinicaltrials.gov

Share:
Add to list

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

Study ID: NCT05467748
Start Date: 2025-11-17
End Date: 2029-11-16
Study Type

Interventional

Study Phase

Phase2

No. of Participants

66

Intervention / Treatment

Tulmimetostat

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

Study ID: NCT07216404
Start Date: 2025-11-20
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

10

Intervention / Treatment

Biospecimen Collection

Counseling

Interview

Psilocybin

Survey Administration

Sponsor

Alan Davis

Source: clinicaltrials.gov

Share:
Add to list

Asian Gynecological Brachytherapy Registry in Cervical Cancer

Study ID: NCT07196033
Start Date: 2026-01
End Date: 2028-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment
Sponsor

Tata Memorial Hospital

Source: clinicaltrials.gov

Share:
Add to list

Improving Cognitive Rehabilitation Outcomes

Study ID: NCT07055633
Start Date: 2026-04-01
End Date: 2030-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

144

Intervention / Treatment

CCT+MBLT

CCT+ION

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Trial of Extended (High) Treatment Dose Antibiotics in Combination With Methenamine Hippurate Compared to the Standard of Care (Either Prophylactic (Low) Dose Antibiotic Treatment or Methenamine Hippurate) in Females With Chronic Urinary Tract Infection

Study ID: NCT07202949
Start Date: 2025-12
End Date: 2027-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

192

Intervention / Treatment

Treatment dose antibiotic in combination with methenamine hippurate

Prophylactic dose antibiotic or methenamine hippurate monotherapy

Sponsor

University College, London

Source: clinicaltrials.gov

Share:
Add to list

A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment

Study ID: NCT07179315
Start Date: 2026-01-01
End Date: 2029-11-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

68

Intervention / Treatment

cemiplimab+fianlimab

Cemiplimab

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Oral THC and CBD in Men and Women

Study ID: NCT05067387
Start Date: 2026-01-15
End Date: 2028-03
Study Type

Interventional

Study Phase

Phase1

No. of Participants

22

Intervention / Treatment

Placebo

THC

CBD

THC + CBD

Sponsor

University of California, Los Angeles

Source: clinicaltrials.gov

Share:
Add to list

The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature

Study ID: NCT05067998
Start Date: 2025-12-21
End Date: 2026-09-17
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

IV Vitamin Infused Therapy Treatment

Herbal medicine

Sponsor

Faith A. Richardson

Source: clinicaltrials.gov

Share:
Add to list